Negative pressure wound therapy
Helping to manage different wounds
In wound care, treating each patient uniquely is essential, as no two wounds are the same. Negative pressure wound therapy (NPWT), a breakthrough in wound management, offers an innovative approach to personalized care by creating an environment that promotes wound healing. By applying continuous or intermittent sub-atmospheric pressure, NPWT works to help remove exudate and infectious materials from the wound bed, reducing edema and promoting tissue perfusion and granulation tissue formation.
We offer a range of NPWT solutions to help patients across the continuum of care. Our solutions have been shown in comparative clinical studies to help reduce the cost of care and improve patient outcomes.3-5
Types of wounds
Our comprehensive NPWT portfolio help promote healing across diverse wound types and across the care continuum, including but not limited to:
Your partner for trusted, reliable NPWT solutions
Choosing a wound management system is an important decision. As your partner in wound management, we’re committed to providing solutions that support your patients' wound healing outcomes throughout their treatment journey. Explore our proven solutions.
Support clinicians can rely on
You need more than a product; you need a trusted partner. From initiation to discharge, we’re here to help you, your team and your patients, with solutions, customer support and resources to guide you every step of the way.
You need more than a product; you need a trusted partner. From initiation to discharge, we’re here to help you, your team and your patients, with solutions, customer support and resources to guide you every step of the way.
We can provide you with:
Evidence-based solutions
Our comprehensive portfolio of advanced wound care solutions is supported by clinical evidence across new and growing categories— including dressings, disposables, digital technology and connectivity.
World-class resources
Access free, live and on-demand webinars to deepen your knowledge of wound care and improve patient care and outcomes.
We can provide you with:
Evidence-based solutions
Our comprehensive portfolio of advanced wound care solutions is supported by clinical evidence across new and growing categories— including dressings, disposables, digital technology and connectivity.
Ongoing support
Getting started is easy with online ordering and scheduled same-day delivery. Our team is available 24/7 to assist you with onsite clinical and technical support.
World-class resources
Access free, live and on-demand webinars to deepen your knowledge of wound care and improve patient care and outcomes.
V.A.C.® Partnership Program
Put your patients first by leaving device management to us. Ensure your patients get the care they need with the V.A.C.® Partnership Programs. Our team understands the daily needs of clinicians and enables them to deliver the best standard of care to every patient.
Explore more
Indication(s) For Use / Intended Use: US FDA Cleared: Only for Use in the United States:
Prevena Dressing used with Prevena Therapy Units: PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible PREVENA™ dressings for up to seven days, PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units are intended to aid in reducing the incidence of seroma; and in patients at high risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and Class II wounds.
Limitations:
- The device is not intended to treat surgical site infection or seroma.
- Safety and effectiveness in pediatric population (<22 years old) have not been evaluated.
- Safety and effectiveness in Class III (Contaminated) and Class IV (Dirty/Infected) wounds have not been demonstrated. Furthermore, Class IV surgical wounds are not expected to be closed primarily, and the subject device should only be used on closed surgical incisions.
- The device has not been demonstrated to reduce deep incisional and organ space surgical site infections.
- The device has not been demonstrated to be effective in reducing the incidence of surgical site infection and seroma in all surgical procedures and patient populations; therefore, the device may not be recommended for routine use to reduce the incidence of surgical site infection and seroma.
- Please refer to the ‘Summary of Clinical Information’ section for the specific surgical procedures and patient populations included in the clinical studies. Surgeons should continue to follow the ‘Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection’11 and the ‘American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines’12 for best practices in preventing surgical site infection. US FDA Cleared: Dressings/ Systems (Prevena Dressings used with compatible Solventum NPWT units - ActiVAC, Ulta, and RX4) and applicable OUS countries that leverage US Indication: The PREVENA™, PREVENA PLUS™, PREVENA DUO™, and PREVENA RESTOR™ Incision Management Systems are intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.
References:
- KCI. Cumulative NPWT Wounds—10 million. 2013-2015. Internal Report (v1.0). 2018.
- KCI. Percentage of V.A.C. Therapy Articles vs. Comp Articles. May 7, 2020
- Yang CK, Alcantara S, Goss S, Lantis JC 2nd. Cost analysis of negative-pressure wound therapy with instillation for wound bed preparation preceding split-thickness skin grafts for massive (>100 cm(2)) chronic venous leg ulcers. J Vasc Surg. 2015 Apr;61(4):995-9.
- Law A, Cyhaniuk A, Krebs B. Comparison of health care costs and hospital readmission rates associated with negative pressure wound therapies. Wounds. 2015 Mar;27(3):63-72.
- Kwon J, Staley C, McCullough M, Goss S, Arosemena M, Abai B, Salvatore D, Reiter D, DiMuzio P. A randomized clinical trial evaluating negative pressure therapy to decrease vascular groin incision complications. J Vasc Surg. 2018 Dec;68(6):1744-1752.
- Law A L Krebs B. Karnik B. Griffin L. Comparison of Healthcare Costs Associated With Patients Receiving Traditional Negative Pressure Wound Therapies in the Post Acute Setting. Cureus 12(11): e11790. DOI 10.7759/cureus.11790.
- Page JC, Newsander B, Schwenke DC, Hansen M, Ferguson J. Retrospective analysis of negative pressure wound therapy in open foot wounds with significant soft tissue defects. Adv Skin Wound Care/ 2004;17(7):354-364.
- Baharestani MM. Driver VR. Optimizing clinical and cost effectiveness with early intervention of V.A.C.® Therapy. Ostomy Wound Manage. 2008;54(11 Suppl):1-15.
- Kim PJ, Lookess S, Bongards C, Griffin LP, Gabriel A. Economic model to estimate cost of negative pressure wound therapy with instillation vs control therapies for hospitalised patients in the United States, Germany, and United Kingdom. International Wound Journal. 2022 May;19(4):888-894.
- Cooper HJ, Singh DP, Gabriel A, Mantyh C, Silverman R, Griffin L. Closed Incision Negative Pressure Therapy Versus Standard of Care Over Closed Surgical Incisions in the Reduction of Surgical Site Complications: A Systematic Review and Meta-Analysis of Comparative Studies. Plastic and Reconstructive Surgery – Global Open. 2023 Mar 16;11(3):e4722.
- Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., Dellinger, E. P., Itani, K. M., Berbari, E. F., Segreti, J., Parvizi, J., Blanchard, J., Allen, G., Kluytmans, J. A., Donlan, R., & Schecter, W. P. (2017). Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery, 152(8), 784. https://doi.org/10.1001/jamasurg.2017.0904
- Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., Itani, K. M. F., Dellinger, P. E., Ko, C. Y., & Duane, T. M. (2017). American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 update. Journal of the American College of Surgeons, 224(1), 59–74. https://doi.org/10.1016/j.jamcollsurg.2016.10.029